{
    "Trade/Device Name(s)": [
        "Quantia Beta-2 Microglobulin"
    ],
    "Submitter Information": "Biokit S.A.",
    "510(k) Number": "K072078",
    "Predicate Device Reference 510(k) Number(s)": [
        "K943686",
        "K050613",
        "K050596",
        "K851202/A1"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JZG"
    ],
    "Summary Letter Date": "November 12, 2007",
    "Summary Letter Received Date": "November 14, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5630"
    ],
    "Regulation Name(s)": [
        "Beta-2-microglobulin immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Beta-2-microglobulin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (EDTA)",
        "Urine"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "AEROSET Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Latex particle enhanced immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Immunoturbidimetric assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Control",
        "Standard",
        "Kit",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Quantia Beta-2 Microglobulin immunoturbidimetric assay for quantitative determination of beta-2-microglobulin in serum, plasma, or urine using AEROSET instrument.",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of beta-2-microglobulin concentration in human serum, plasma (EDTA), or urine as an aid in the diagnosis of active rheumatoid arthritis and kidney disease.",
    "fda_folder": "Immunology"
}